Stay updated on Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new revision entry v3.5.0 has been added and the previous entry v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-19T23:29:56.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added revision v3.4.3 and removed revision v3.4.2 in the record history.
    Difference
    0.1%
    Check dated 2026-03-12T18:38:51.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The new screenshot shows a visual/UI refresh while the version history details remain the same; no substantive changes to study records are evident.
    Difference
    0.1%
    Check dated 2026-02-26T15:22:04.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Record History now includes Revision: v3.4.2 and removes Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T02:19:29.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The history now includes a new revision entry for v3.4.1 and removes v3.4.0, affecting only version-tracking metadata and not study details or user-facing content; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:30:12.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The Study Record Versions page now shows a glossary toggle, uses green and red highlights to denote additions and deletions, and updates the revision label to v3.4.0; capitalization for the No FEAR Act label was adjusted.
    Difference
    0.9%
    Check dated 2026-01-28T19:22:36.000Z thumbnail image

Stay in the know with updates to Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.